Market Place
Sourcing Support
Avalyn Presents Inhaled Pirfenidone At Lung Fibrosis Colloquium
30 Sep 2024 //
GLOBENEWSWIRE
Avalyn Presents AP01 Data For Pulmonary Fibrosis At ERS 2024
08 Sep 2024 //
GLOBENEWSWIRE
Avalyn Begins Global Phase 2b MIST Study for AP01 in Pulmonary Fibrosis
03 Sep 2024 //
GLOBENEWSWIRE
Avalyn to Present Data for Pulmonary Fibrosis at European Respiratory Congress
26 Aug 2024 //
GLOBENEWSWIRE
Avalyn Announces Presentations On AP01 For Pulmonary Fibrosis At ERS Congress
26 Aug 2024 //
GLOBENEWSWIRE
Bridge Biotherapeutics Completes Enrollment For BBT-877 IPF Phase 2a Study
29 Jul 2024 //
PR NEWSWIRE
Health Canada Issues Recalls of Pharmascience`s PMS Pirfenidone
07 Jun 2024 //
HEALTH CANADA
Avalyn Presents AP01 Long-Term, Imaging Data In Pulmonary Fibrosis
20 May 2024 //
GLOBENEWSWIRE
Avalyn Presents On AP01, Novel Inhaled Therapies At ATS 2024
13 May 2024 //
GLOBENEWSWIRE
Roche is `evaluating options` for IPF drug Esbriet as generics gain traction
27 Feb 2024 //
ENDPTS
Roche sues Novartis unit over generic lung disease drug
02 Aug 2023 //
REUTERS
Apotex`s Generic Pirfenidone Receives Approval in the U.S.
09 Jun 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Viatris`s Pirfenidone Receives Approval in Europe
17 Jan 2023 //
EMA
Viatris`s Pirfenidone Viatris (pirfenidone) Receives Approval in Europe
17 Jan 2023 //
EMA
Hetero`s Generic Pirfenidone Receives Approval in the U.S.
21 Sep 2022 //
FDA
ScieGen Pharma`s Generic Pirfenidone Receives Approval in the U.S.
01 Aug 2022 //
FDA
Aizant Generic Pirfenidone Receives Approval in the U.S.
21 Jul 2022 //
FDA
Laurus Labs Generic Pirfenidone Receives Approval in the U.S.
19 Jul 2022 //
FDA
Alfred E. Tiefenbacher`s Pirfenidone Receives Approval in the EMA
28 Jun 2022 //
FDA
Alfred E. Tiefenbacher` Pirfenidone AET Receives Approval in Europe
28 Jun 2022 //
EMA
Sandoz B2B Generic Pirfenidone Receives Approval in the U.S.
13 Jun 2022 //
FDA
Accord Healthcare Releases Generic Drug Proven Effective Against IPF
01 Jun 2022 //
BIOSPACE
Alembic Pharma gets USFDA approval to market Pirfenidone tablets
24 May 2022 //
BUSINESS-STANDARD
Sandoz launches first US generic of Roche`s Esbriet
14 May 2022 //
FIERCEPHARMA
Sandoz launches first generic pirfenidone in US for patients with IPF
12 May 2022 //
PRNEWSWIRE
Four Drugs Recommended For Approval By Chmp At April Meeting
25 Apr 2022 //
MEDWATCH
Amneal Pharm`s Generic Pirfenidone Receives Approval in the U.S.
25 Mar 2022 //
FDA
Teva Pharms USA`s Generic Pirfenidone Receives Approval in the U.S.
25 Jan 2022 //
FDA
Accord Healthcare`s Generic Pirfenidone Receives Approval in the U.S.
20 Jan 2022 //
FDA
PureTech’s LYT-100 Shows 50% Reduction against GI-Related AEs vs Pirfenidone
05 Jan 2022 //
BUSINESSWIRE
Amneal`s Generic Pirfenidone Receives Approval in the U.S.
03 Jan 2022 //
FDA
Alembic Pharms`s Generic Clomipramine HCl Receives Approval In US
30 Oct 2021 //
FDA
Alembic Pharms`s Generic Pirfenidone Receives Approval In US
30 Oct 2021 //
FDA
Pirfenidone could offer ‘viable’ heart failure treatment
16 Aug 2021 //
PHARMATIMES
Sandoz`s Generic Pirfenidone Receives Approval in US
31 Mar 2021 //
FDA
With patent concerns looming, Roche new priority review on blockbuster IPF drug
22 Jan 2021 //
ENDPTS
FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone)
21 Jan 2021 //
BUSINESSWIRE
FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone)
20 Jan 2021 //
BUSINESSWIRE
Risk of drug-induced liver injury associated with the use of pirfenidone
09 Dec 2020 //
HSA
Sciegen Pharms Generic Pirfenidone Receives Tentative Approval In US
18 Nov 2020 //
FDA
Teva Pharma`s USA Generic Pirfenidone Receives Approval in US
22 Aug 2020 //
FDA
MSN Labs Generic Pirfenidone Receives Tentative Approval In US
10 Aug 2020 //
FDA
PureTech eyes clinical trial in long-term COVID-19 complications
30 May 2020 //
FIERCE BIOTECH
Amneal Pharmaceuticals` Generic Pirfenidone Receive Approval in U.S
26 Mar 2020 //
FDA
Roche pushes to kick-start lung therapy Esbriet after big writedown
04 Mar 2020 //
PRESS RELEASE
FDA Grants Breakthrough Therapy Designation for Genentech’s Esbriet pirfenidone
02 Mar 2020 //
BUSINESSWIRE
Shilpa Medicare`s Generic Pirfenidone Receives Tentative Approval in US
31 Jan 2020 //
FDA
Apotex`s Generic Pirfenidone Receives Tentative Approval in US
30 Oct 2019 //
FDA
Apotex`s Generic Pirfenidone Receives Tentative Approval in US
01 Oct 2019 //
FDA
Boehringer Ingelheim`s Ofev wins FDA approval for use in scleroderma patients
10 Sep 2019 //
ENDPOINTSNEWS
Esbriet® (pirfenidone) : Genentech vs. Macleods Pharmaceuticals
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Accord Healthcare
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Teva Pharmaceuticals
30 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. ScieGen Pharmaceuticals
29 Jan 2019 //
PATENT LITIGATION
Esbriet® (pirfenidone) : Genentech vs. Laurus Labs
15 Jan 2019 //
PATENT LITIGATION
Tium Bio Licenses out Lung Disease Drug Candidate for US$74 Mil
11 Jan 2019 //
KOREA BUSINESS
ESBRIET (Pirfenidone) Film Coated Tablets, 534 mg
04 Jan 2019 //
FEDERAL REGISTER
